Navigation Links
Video: New Insights Link Low HDL-Cholesterol and Elevated Triglycerides with Coronary Heart Disease and Microvascular Complications in Patients at Goal for LDL-Cholesterol
Date:9/1/2009

taires Saint-Luc, Brussels, Belgium

References:

(1) Fruchart JC, Sacks F, Hermans MP, Assmann G, Brown WV, Ceska R, et al. The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia. Am J Cardiol. 2008;102 (Suppl):1K-34K.

(2) Fruchart JC, Sacks F, Hermans MP, Assmann G, Brown WV, Ceska R, et al. The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia. Diab Vasc Dis Res. 2008; 5:319-35.

(3) Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, et al; Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366:1267-78.

(4) Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348:383-393.

(5) Alsheikh-Ali AA, Lin JL, Abourjaily P, Ahearn D, Kuvin JT, Karas RH. Prevalence of low highdensity lipoprotein cholesterol in patients with documented coronary heart disease or riskequivalent and controlled low-density lipoprotein cholesterol. Am J Cardiol. 2007;100:1499-1501.

(6) Ninomiya JK, L'Italien G, Criqui MH, Whyte JL, Gamst A, Chen RS. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation. 2004;109:42-46.

(7) Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683-689.

(8) Miller M, Cannon CP, Murphy SA, Qin J, Ray KK, Braunwald E. Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in
'/>"/>

SOURCE Residual Risk Reduction Initiative Foundation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Video: Nutrition Comes to NASCAR
2. Video: Circulatory Care of New Jersey
3. Video: GEN Video Hits Home with Web Audience
4. Video: Beyond the Red Door: Gildas Club Worldwide and DKNY Host Successful Benefit Event
5. Video: Food Expert B. Smith to Provide Healthy Menu Makeovers
6. Video: New FDA-Approved Sun Protectant Saves Skin All Year Round
7. Video: Kyphon Supports World Osteoporosis Day on October 20, 2007 to Raise Awareness of Osteoporosis and Spinal Fracture Risk
8. Video: Trinity Mother Frances Neurosurgeon First in Region to Remove Brain Tumor Using Unique Surgical Procedure
9. Video: Holiday Safety Is Important
10. Video: Grin Big With an Award-Winning Smile
11. Video: BSP Pharma Inc. Announces Groundbreaking Findings from The Australian Centre for Complementary Medicine Education and Research Joint Health Clinical Study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)..., (Seattle, Washington) November 20, 2009Emergenc...ates assess an estimated 350,000 cardiac arrests e... sudden cardiac arrest survive. Better quality ca...ospital EMS providers may be associated with bette...sortium (ROC) is the largest clinical research net...
(Date:11/20/2009)... 1 in 4 thinks it,s as short as 34 weeks, potentia..., , FRIDAY, Nov. 20 (HealthDay News) -- R...ries continues to climb in the United States. Now...are confused about what constitutes a full-term bi...new mothers surveyed in the study considered a bab...
(Date:11/20/2009)... Canadian study finds more severe cases than with ...hDay News) -- Canadian researchers are reporting t...p severe cases of H1N1 flu than seasonal flu. ,... factor for admission with pandemic H1N1 influenza...r samples," wrote Dr. Upton Allen and fellow resea...
(Date:11/20/2009)..., Longtime OB/GYN warns a...sed by the U.S. Preventative Services Task Force. ...ome at the price of human lives. When is it wrong ...The new U.S. Preventative Services Task Force reco... Annals of Internal Medicine, has set off a firest...
(Date:11/20/2009)..., , SPRINGFIELD, Mo., Nov. 20 /PRNewswire/...South Central Missouri regions will now have the o...reement reached Tuesday between Missouri Consolida...s. ,, The Southwest and South Central Missouri ...ton, Cedar, Christian, Dade, Dallas, Douglas, Gree...
Breaking Medicine News(10 mins):Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3Health News:Many Women Miscalculate Time to Full-Term Birth 2Health News:Many Women Miscalculate Time to Full-Term Birth 3Health News:Many Women Miscalculate Time to Full-Term Birth 4Health News:New Breast Cancer Recommendation May Cost Lives While Saving Money 2Health News:New Breast Cancer Recommendation May Cost Lives While Saving Money 3Health News:Missouri Consolidated Health Care Plan Provides Mercy Health Plans Option 2
... medicines with the right food could improve the e...apidly rising costs of treating patients, experts ...ists Mark Ratain, MD, and Ezra Cohen, MD, have rel...d absorption of the drug. Previo...
...n example for others to follow, the Varanavasi Vil...imposed a ban on tobacco consumption among village...of tobacco consumption, the village panchayat unan...cco products like cigarette and gutka. Hence, the ...
...lly should stop complaining about their problems w...se who do so, are at a greater risk of developing ...ciate professor of psychological sciences in the C... seventh and ninth grade students - boys and girls...
...n minister in charge of womens affairs has announc...up hospices for HIV positive women . Minis...ry said, "We plan to start hospices in villages fo...iant." The hospices would be in village...
...s in the US have claimed that scorpion venom may h... Scorpions occur naturally in parts of Afri... of scorpions are harmless to human beings althoug... in scorpion venom can distinguish cancer from hea...
... origin scientist at the Rensselaer Polytechnic In...artificial muscles using carbon nanofibres . ...stimulus, thereby creating a smoother, more human-...mplantation, say scientists. Today's most pro...
Other Medicine News:Health News:Right Foods Could Improve Drug Effectiveness, Lower Drug Costs 2Health News:Village Panchayat in Tamil Nadu Bans Tobacco Consumption 2Health News:Complaining Girls Faces Higher Depression, Anxiety Risk 2Health News:India Plans Hospices for HIV Positive Women 2
(Date:11/20/2009)...tCall/ -- Biotel Inc. (OTC Bulletin Board: BTEL) a...mber 30, 2009 with net earnings of $128,000, or $0... This compares to net earnings of $328,000, or $0....r the first quarter of last year. ,, Commenting...d CEO Steve Springrose said: "Biotel enjoyed stron...
(Date:11/20/2009)...re-FirstCall/ -- Soligenix, Inc. (OTC Bulletin Boa...wn as DOR BioPharma, Inc., a late-stage biotechnol...consortium to develop thermostable technology to a.... Soligenix received a $9.4 million grant from the...ases (NIAID), a division of the National Institute...
(Date:11/19/2009)...swire-Asia/ -- ScinoPharm, a leading global,suppli...nounced that its,Tainan facility has received the ...ge(R) Consultants, Inc. The Certification confirms...fe handling of potent active,pharmaceutical ingred... and,production areas used for the manufacturing a...
Breaking Medicine Technology:Biotel Announced Profitable First Quarter Ended September 30, 2009 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2Transgenomic Inc Reports Second Quarter 2009 Results 13536 1Transgenomic Inc Reports Second Quarter 2009 Results 13536 2Transgenomic Inc Reports Second Quarter 2009 Results 13536 3Transgenomic Inc Reports Second Quarter 2009 Results 13536 4Transgenomic Inc Reports Second Quarter 2009 Results 13536 5Transgenomic Inc Reports Second Quarter 2009 Results 13536 6Transgenomic Inc Reports Second Quarter 2009 Results 13536 7Transgenomic Inc Reports Second Quarter 2009 Results 13536 8St Anthonys Hospital Offers First Ambient MRI In Florida 4849 1St Anthonys Hospital Offers First Ambient MRI In Florida 4849 2St Anthonys Hospital Offers First Ambient MRI In Florida 4849 3Scientists demonstrate importance of niche differences in biodiversity 9554 1Scientists demonstrate importance of niche differences in biodiversity 9554 2
...ralia, March 27, 2007--CSL Limited,today announced...the American Medical Association that suggest infu...se HDL (“good”,cholesterol) levels, ma...ries of patients with a recent episode of acute,co...ct of Reconstituted HDL on,Atherosclerosis –...
...tudy Demonstrates 50% Survival in Valortim-Treated...rch 29, 2007,/PRNewswire-FirstCall/ -- Medarex, In...armAthene, Inc., a privately held,biotechnology co...ountermeasures, today announced that Valortim(TM),...te being developed for the,prevention and treatmen...
Other Medicine Technology:CSL Therapy That Mimics “Good” Cholesterol May Reduce,Plaque Volume in Coronary Arteries 2CSL Therapy That Mimics “Good” Cholesterol May Reduce,Plaque Volume in Coronary Arteries 3Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 2Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 3Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 4Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 5Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 6Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 7Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 8
...em is the worlds first tri-modal cataract removal ...lows surgeons to,choose from three different met...tem features revolutionary Fluidics and unique tri...ase Liquefaction Device, Ultrasound and NeoSoniX h...
...omputerized medical record system whose goal is to...ractice as well as improve the degree and ease of ...commonly presenting problems based on the chief co...o cover rare diagnostic entities. It covers the ch...
Veatch 2V
ReSeeVit 5Z
Medicine Products: